tiprankstipranks
Cynata Therapeutics Limited (AU:CYP)
ASX:CYP
Australian Market
CYP
Cynata Therapeutics Limited
RESEARCH TOOLSreports

Cynata Therapeutics Limited (CYP) Stock News & Sentiment

9 Followers
Cynata Options Expire Unexercised, Streamlining Capital Structure
Premium
Company Announcements
Cynata Options Expire Unexercised, Streamlining Capital Structure
6d ago
Cynata Reaches Key Phase 2 Milestone in aGvHD as Late-Stage Cell Therapy Pipeline Advances
Premium
Company Announcements
Cynata Reaches Key Phase 2 Milestone in aGvHD as Late-Stage Cell Therapy Pipeline Advances
14d ago
Cynata Narrows Half-Year Loss but Faces Going Concern Uncertainty
Premium
Company Announcements
Cynata Narrows Half-Year Loss but Faces Going Concern Uncertainty
2M ago
Cynata to Host Investor Webinar and Expand Online Engagement With Shareholders
Premium
Company Announcements
Cynata to Host Investor Webinar and Expand Online Engagement With Shareholders
2M ago
Cynata Nears Key Data Readouts as Pivotal Cell Therapy Trials Advance
Premium
Company Announcements
Cynata Nears Key Data Readouts as Pivotal Cell Therapy Trials Advance
2M ago
Cynata Raises $1.2m via At-The-Market Facility to Support Cell Therapy Pipeline
Premium
Company Announcements
Cynata Raises $1.2m via At-The-Market Facility to Support Cell Therapy Pipeline
3M ago
Cynata Completes Enrollment in Phase 2 aGvHD Trial
Premium
Company Announcements
Cynata Completes Enrollment in Phase 2 aGvHD Trial
4M ago
More AU:CYP News >

CYP News on the Web

Morgans names seven ASX healthcare stocks with upcoming catalysts
StockHead
Neutral
Biocurious: Battered local biotech valuations provide golden opportunities
StockHead
Neutral
Cynata Options Expire Unexercised, Streamlining Capital Structure
TipRanks News
Neutral
Cynata hits century mark in phase II aGvHD trial
StockHead
Bullish
Health Check: If you#8217;ve got a good story to tell, dip into the funding well
StockHead
Neutral
Cynata Reaches Key Phase 2 Milestone in aGvHD as Late-Stage Cell Therapy Pipeline Advances
TipRanks News
Bullish
Japan’s milestone iPSC approval puts Cynata’s platform in spotlight
StockHead
Neutral
Cynata Narrows Half-Year Loss but Faces Going Concern Uncertainty
TipRanks News
Bearish

News Score - Last 7 Days

Neutral
AU:CYP
Sector Average
Media Buzz
This Week3 articles
Weekly Average1.75 articles
News Sentiment
This Week100%
Sector Average68%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is AU:CYP’s Media Buzz Sentiment?
3 articles about AU:CYP were published this week. In an average week, 1.75 articles are published.
    What is AU:CYP’s weekly average amount of articles?
    In an average week, 1.75 articles about AU:CYP are published.
      What is AU:CYP’s News Sentiment?
      100% of articles about AU:CYP were positive this week, compared to its sector average of 68%.
        Healthcare Stocks that are Trending in the News
        AORTArtivion
        NBIXNeurocrine
        STAAStaar Surgical
        SLPSimulations Plus
        OWLTOwlet
        Showing the stocks with the most bullish news sentiment over the past week